Shandong Xinhua Pharmaceutical Company Limited provided earnings guidance for the quarter ended March 31, 2017. The Group is expected to record an increase in the net profit attributable to the Shareholders for the period from 1 January 2017 to 31 March 2017 as compared to the corresponding period in 2016. Net Profits Attributable to the equity holders of the company was an increase of approximately 130%-180% as compared with the same period last year. Profit is expected to be approximately from RMB 47,000,000 to RMB 56,000,000. Basic Earnings Per Share is expected approximately from RMB 0.10 to RMB 0.12. Reasons of changes in performance: Progress in product techniques and reduced energy and raw material consumption during the reporting Period. Active exploration of the market and expansion of sales volume.